{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T18:07:40Z","timestamp":1794506860943,"version":"4.9.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"European Union - Next Generation EU","award":["NRRP M6C2 -PNRR-MR1-2022-12376604"],"award-info":[{"award-number":["NRRP M6C2 -PNRR-MR1-2022-12376604"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Neurofibromatosis type 1 (NF1) is a neurocutaneous disorder characterized by a potential multisystemic involvement. The musculoskeletal system is frequently affected (i.e.: scoliosis, thorax anomalies, tibial dysplasia). The segmental overgrowth of lower limb (SOLL) is rarely reported, albeit it severely affects patients\u2019 wellbeing. The resulting leg length discrepancy (LLD) negatively impacts the development of the musculoskeletal system and may require appropriate correction, which could include surgery. Our objective was to evaluate the prevalence, the management, and the outcomes in patients with SOLL and NF1. We retrospectively evaluated 553 pediatric patients seen between 1992 and 2024 with a diagnosis of NF1. All patients presenting with SOLL were included in the study. For each patient, we assessed the degree of LLD at the initial evaluation, at the time of surgery (if any), at the point of maximum discrepancy, and at last visit. Demographic data, associated deformities, presence and location of plexiform neurofibroma (PN) were registered. Each patient and\/or their parents were also evaluated using the Gait Outcome Assessment List for lower-limb differences (GOAL-LD) questionnaire to assess the health-related quality of life of pediatric patients with LLD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>7 patients (4 males) with a mean age at diagnosis of SOLL of 4.67 years met our inclusion criteria. The detected discrepancies ranged from 0.5 cm to 6 cm (mean 4.30). Five children underwent surgery for the discrepancy (3 with epiphysiodesis and 2 with external fixation limb lengthening). All patients but one presented a plexiform neurofibroma in the district of SOLL that has been treated by selumetinib in 3 cases. Two patients were treated conservatively using lifted insoles. The GOAL-LD questionnaire revealed low scores in all the domains evaluated (function and mobility, pain and fatigue, physical and recreational activity, gait appearance, use of braces and walking aids, body image, and self-esteem).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>SOLL-related LLD in patients with NF1 is a complex condition with significant impact on quality of life. Outcomes are often suboptimal, underlying the need for individualized, multidisciplinary management and structured follow-up. Early detection of progression is crucial to guide timely therapeutic decisions. Further prospective, multicenter studies are needed to better clarify pathogenic mechanisms and to develop standardized treatment protocols.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-025-04190-5","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T07:52:02Z","timestamp":1768204322000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prevalence and management of lower limb segmental overgrowth in patients with NF1: an observational study"],"prefix":"10.1186","volume":"21","author":[{"given":"Claudia","family":"Santoro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Conza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Itro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Colonnese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niccol\u00f2","family":"Garofalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Piluso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluigi","family":"Federico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Paoletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Liguori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antimo","family":"Moretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silverio","family":"Perrotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8560-721X","authenticated-orcid":false,"given":"Giuseppe","family":"Toro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"4190_CR1","doi-asserted-by":"crossref","unstructured":"Lee TSJ, Chopra M, Kim RH, Parkin PC, Barnett-Tapia C. Incidence and prevalence of neurofibromatosis type 1 and 2: a systematic review and meta-analysis. Orphanet J Rare Dis 2023 Sept 14;18(1):292.","DOI":"10.1186\/s13023-023-02911-2"},{"key":"4190_CR2","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.5604\/17322693.1185213","volume":"69","author":"A Abramowicz","year":"2015","unstructured":"Abramowicz A, Gos M. [Neurofibromin - protein structure and cellular functions in the context of neurofibromatosis type I pathogenesis]. Postepy Hig Med Doswiadczalnej Online. 2015;69:1331\u201348.","journal-title":"Postepy Hig Med Doswiadczalnej Online"},{"issue":"8","key":"4190_CR3","first-page":"1506","volume":"23","author":"E Legius","year":"2021","unstructured":"Legius E, Messiaen L, Wolkenstein P, Pancza P, Avery RA, Berman Y, et al. Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation. Genet Med Off J Am Coll Med Genet. 2021;23(8):1506\u201313.","journal-title":"Genet Med Off J Am Coll Med Genet"},{"issue":"2","key":"4190_CR4","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/sj.ejhg.5201676","volume":"15","author":"RE Ferner","year":"2007","unstructured":"Ferner RE. Neurofibromatosis 1. Eur J Hum Genet EJHG. 2007;15(2):131\u20138.","journal-title":"Eur J Hum Genet EJHG"},{"issue":"11","key":"4190_CR5","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1177\/0883073815571635","volume":"30","author":"FS Pinheiro","year":"2015","unstructured":"Pinheiro FS, Rothner AD, Moodley M, Zahka KG. Massive soft tissue neurofibroma (Elephantiasis Neuromatosa): case report and review of literature. J Child Neurol. 2015;30(11):1537\u201343.","journal-title":"J Child Neurol"},{"key":"4190_CR6","doi-asserted-by":"crossref","unstructured":"Toro G, Santoro C, Ambrosio D, Landi G, Scilipoti M, Moretti A, et al. Natural history of scoliosis in children with NF1: an observation study. Healthcare (Basel). 2021 Jul 13;9(7):881.","DOI":"10.3390\/healthcare9070881"},{"key":"4190_CR7","unstructured":"National Institutes of Health Consensus Development Conference Statement: neurofibromatosis, Bethesda. Md., USA, July 13\u201315, 1987. Neurofibromatosis. 1988;1(3):172\u20138."},{"issue":"5","key":"4190_CR8","doi-asserted-by":"publisher","first-page":"150974","DOI":"10.1016\/j.sempedsurg.2020.150974","volume":"29","author":"W Eng","year":"2020","unstructured":"Eng W, Hammill AM, Adams DM. Overgrowth syndromes and new therapies. Semin Pediatr Surg. 2020;29(5):150974.","journal-title":"Semin Pediatr Surg"},{"issue":"1","key":"4190_CR9","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12955-021-01775-z","volume":"19","author":"JA Dermott","year":"2021","unstructured":"Dermott JA, Wright FV, Salbach NM, Narayanan UG. Development of the gait outcomes assessment list for lower-limb differences (GOAL-LD) questionnaire: a child and parent reported outcome measure. Health Qual Life Outcomes. 2021;19(1):139.","journal-title":"Health Qual Life Outcomes"},{"issue":"6","key":"4190_CR10","doi-asserted-by":"publisher","first-page":"645","DOI":"10.3390\/genes16060645","volume":"16","author":"G Miele","year":"2025","unstructured":"Miele G, Russo I, Filipponi L, Perrotta S, Maida E, Piluso G, et al. Clinical efficacy of selumetinib in alleviating neuropathic pain associated with plexiform neurofibroma: A case series. Genes. 2025;16(6):645.","journal-title":"Genes"},{"issue":"3","key":"4190_CR11","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1007\/s11060-025-05197-5","volume":"175","author":"C Santoro","year":"2025","unstructured":"Santoro C, Servedio M, Diana MC, Russo I, Arkhangelskaya E, Piccolo G, et al. Real-world experience with selumetinib in children with neurofibromatosis type 1: a multicentric retrospective study. J Neurooncol. 2025;175(3):1027\u201337.","journal-title":"J Neurooncol"},{"issue":"2","key":"4190_CR12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0966-6362(01)00148-5","volume":"15","author":"B Gurney","year":"2002","unstructured":"Gurney B. Leg length discrepancy. Gait Posture. 2002;15(2):195\u2013206.","journal-title":"Gait Posture"},{"key":"4190_CR13","doi-asserted-by":"crossref","unstructured":"Duffy KA, Davidson RS, Kalish JM. Understanding syndromic leg length discrepancy. J Pediatr. 2021 July;234:16\u20138.","DOI":"10.1016\/j.jpeds.2021.01.076"},{"issue":"4","key":"4190_CR14","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1542\/peds.44.4.584","volume":"44","author":"DA Parker","year":"1969","unstructured":"Parker DA, Skalko RG. Congenital asymmetry: report of 10 cases with associated developmental abnormalities. Pediatrics. 1969;44(4):584\u20139.","journal-title":"Pediatrics"},{"issue":"3","key":"4190_CR15","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/tera.1420010305","volume":"1","author":"I Leck","year":"1968","unstructured":"Leck I, Record RG, McKeown T, Edwards JH. The incidence of malformations in Birmingham, England, 1950\u20131959. Teratology. 1968;1(3):263\u201380.","journal-title":"Teratology"},{"key":"4190_CR16","doi-asserted-by":"crossref","unstructured":"Vaiman M, Shilco P, Roitblat Y, Nehuliaieva L, Rosenberg S, Leit A et al. Hemihyperplasia\/hemihypertrophy in adolescents: prospective international study. Int J Adolesc Med Health. 2019;33(1).","DOI":"10.1515\/ijamh-2018-0066"},{"issue":"10","key":"4190_CR17","first-page":"2409","volume":"36","author":"KV Mladenov","year":"2020","unstructured":"Mladenov KV, Spiro AS, Krajewski KL, St\u00fccker R, Kunkel P. Management of spinal deformities and tibial pseudarthrosis in children with neurofibromatosis type 1 (NF1). Childs Nerv syst ChNS. Off J Int Soc Pediatr Neurosurg. 2020;36(10):2409\u201325.","journal-title":"Off J Int Soc Pediatr Neurosurg"},{"issue":"8","key":"4190_CR18","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/ng2083","volume":"39","author":"J Douglas","year":"2007","unstructured":"Douglas J, Cilliers D, Coleman K, Tatton-Brown K, Barker K, Bernhard B, et al. Mutations in RNF135, a gene within the NF1 microdeletion region, cause phenotypic abnormalities including overgrowth. Nat Genet. 2007;39(8):963\u20135.","journal-title":"Nat Genet"},{"issue":"2","key":"4190_CR19","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/ajmg.a.36836","volume":"167A","author":"KM Keppler-Noreuil","year":"2015","unstructured":"Keppler-Noreuil KM, Rios JJ, Parker VER, Semple RK, Lindhurst MJ, Sapp JC, et al. PIK3CA-related overgrowth spectrum (PROS): diagnostic and testing eligibility criteria, differential diagnosis, and evaluation. Am J Med Genet A. 2015;167A(2):287\u201395.","journal-title":"Am J Med Genet A"},{"issue":"1","key":"4190_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s12306-009-0049-8","volume":"94","author":"G Sabbioni","year":"2010","unstructured":"Sabbioni G, Rani N, Devescovi V. Neurofibromatosis with unilateral lower limb gigantism. Musculoskelet Surg. 2010;94(1):41\u20134.","journal-title":"Musculoskelet Surg"},{"issue":"1","key":"4190_CR21","doi-asserted-by":"publisher","first-page":"59","DOI":"10.4103\/1817-1745.66684","volume":"5","author":"S Bano","year":"2010","unstructured":"Bano S, Prasad A, Yadav SN, Chaudhary V, Sachdeva N. Elephantiasis neuromatosa of the lower limb in a patient with neurofibromatosis type-1: A case report with imaging findings. J Pediatr Neurosci. 2010;5(1):59\u201363.","journal-title":"J Pediatr Neurosci"},{"key":"4190_CR22","doi-asserted-by":"crossref","unstructured":"Ponti G, Pellacani G, Martorana D, Mandel VD, Loschi P, Pollio A, et al. Giant elephantiasis neuromatosa in the setting of neurofibromatosis type 1: a case report. Oncol Lett. 2016 June;11(6):3709\u201314.","DOI":"10.3892\/ol.2016.4469"},{"issue":"1","key":"4190_CR23","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/MOP.0b013e3282f35eeb","volume":"20","author":"L Friend","year":"2008","unstructured":"Friend L, Widmann RF. Advances in management of limb length discrepancy and lower limb deformity. Curr Opin Pediatr. 2008;20(1):46\u201351.","journal-title":"Curr Opin Pediatr"},{"key":"4190_CR24","unstructured":"Reid D, Smith B. Leg length inequality: a review of etiology and management. 1984."},{"issue":"6","key":"4190_CR25","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/S0031-3955(16)36149-1","volume":"33","author":"CF Moseley","year":"1986","unstructured":"Moseley CF. Leg-length discrepancy. Pediatr Clin North Am. 1986;33(6):1385\u201394.","journal-title":"Pediatr Clin North Am"},{"issue":"4","key":"4190_CR26","doi-asserted-by":"publisher","first-page":"520","DOI":"10.2106\/00004623-198870040-00007","volume":"70","author":"JW Pritchett","year":"1988","unstructured":"Pritchett JW. Growth and predictions of growth in the upper extremity. J Bone Joint Surg Am. 1988;70(4):520\u20135.","journal-title":"J Bone Joint Surg Am"},{"issue":"6","key":"4190_CR27","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s11832-016-0778-9","volume":"10","author":"M Gottliebsen","year":"2016","unstructured":"Gottliebsen M, Shiguetomi-Medina JM, Rahbek O, M\u00f8ller-Madsen B. Guided growth: mechanism and reversibility of modulation. J Child Orthop. 2016;10(6):471\u20137.","journal-title":"J Child Orthop"},{"issue":"7","key":"4190_CR28","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1097\/BPO.0000000000000835","volume":"38","author":"MR Makarov","year":"2018","unstructured":"Makarov MR, Dunn SH, Singer DE, Rathjen KE, Ramo BA, Chukwunyerenwa CK, et al. Complications associated with epiphysiodesis for management of leg length discrepancy. J Pediatr Orthop. 2018;38(7):370\u20134.","journal-title":"J Pediatr Orthop"},{"issue":"2","key":"4190_CR29","first-page":"226","volume":"76","author":"C Campens","year":"2010","unstructured":"Campens C, Mousny M, Docquier PL. Comparison of three surgical epiphysiodesis techniques for the treatment of lower limb length discrepancy. Acta Orthop Belg. 2010;76(2):226\u201332.","journal-title":"Acta Orthop Belg"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-04190-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-04190-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-04190-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:35:45Z","timestamp":1781627745000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-025-04190-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4190"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-04190-5","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"assertion":[{"value":"21 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients signed a written informed consent, authorizing data collection for research and audit purposes. Data included in the present study were collected according to our institutional ethical approval (Comitato Etico Universit\u00e0 degli Studi della Campania \u201cLuigi Vanvitelli\u201d \u2013 Azienda Ospedaliera Universitaria \u201cLuigi Vanvitelli\u201d \u2013 AORN \u201cOspedali dei Colli\u201d Prot. 0009133\/i of 24\/03\/2023).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All patients signed a written informed consent allowing for data publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"48"}}